1. Home
  2. Research & Funding
  3. Current Funding Opportunities
  4. Notice of Special Interest: Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed)

Notice of Special Interest: Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed)

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is issuing this Notice of Special Interest (NOSI) to announce the opportunity for investigators to apply for funding for developing novel tools and technologies that enable new lines of scientific inquiry and/or treatment, prevention, or diagnosis of Polycystic Kidney Disease (PKD).

Funding Opportunity Details

NOT-DK-23-013
None

Christine Maric-Bilkan, Ph.D.; Susan Mendley, M.D.

NOTE: The NIDDK does not co-sponsor the NIH Exploratory Developmental Research Grant Program (Parent R21). The NIDDK will continue to accept R21 applications submitted in response to targeted NIDDK solicitations.

Key Dates

4/19/2023

Read full announcement